ArticleTranslational oncology2019

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy.

Akihiko Shimomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.